MX2017008096A - Pestivirus. - Google Patents

Pestivirus.

Info

Publication number
MX2017008096A
MX2017008096A MX2017008096A MX2017008096A MX2017008096A MX 2017008096 A MX2017008096 A MX 2017008096A MX 2017008096 A MX2017008096 A MX 2017008096A MX 2017008096 A MX2017008096 A MX 2017008096A MX 2017008096 A MX2017008096 A MX 2017008096A
Authority
MX
Mexico
Prior art keywords
virus
relates
proteins
pestivirus
novel
Prior art date
Application number
MX2017008096A
Other languages
English (en)
Inventor
Carla Christina Schrier
GUELEN Lars
Deijs Martin
De Groof Ad
Maria Van Der Hoek Cornelia
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2017008096A publication Critical patent/MX2017008096A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G01N2333/183—Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus) or border disease virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)

Abstract

La presente invención está relacionada a un pestivirus de porcino novedoso, a proteínas del virus y a vacunas basadas en el virus y proteínas del mismo; la invención también está relacionada a fragmentos de ADN que comprenden un gen del virus y vacunas de ADN basadas en los genes del virus; además, la invención se relaciona con anticuerpos que son reactivos con el virus novedoso y con pruebas de diagnóstico para la detección del virus o de anticuerpos contra el virus.
MX2017008096A 2014-12-19 2015-12-18 Pestivirus. MX2017008096A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14199430 2014-12-19
PCT/EP2015/080400 WO2016097245A1 (en) 2014-12-19 2015-12-18 Pestivirus

Publications (1)

Publication Number Publication Date
MX2017008096A true MX2017008096A (es) 2017-10-31

Family

ID=52278411

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017008096A MX2017008096A (es) 2014-12-19 2015-12-18 Pestivirus.

Country Status (13)

Country Link
US (1) US10954491B2 (es)
EP (1) EP3233890B1 (es)
JP (1) JP6772137B2 (es)
KR (1) KR102472939B1 (es)
CN (1) CN107002047B (es)
BR (1) BR112017012484B1 (es)
CA (1) CA2968912A1 (es)
DK (1) DK3233890T3 (es)
ES (1) ES2717544T3 (es)
MX (1) MX2017008096A (es)
PL (1) PL3233890T3 (es)
RU (1) RU2710041C2 (es)
WO (1) WO2016097245A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140170180A1 (en) 2012-12-17 2014-06-19 Boehringer Ingelheim Vetmedica, Inc. Porcine parvovirus 5a, methods of use and vaccine
PL3233890T3 (pl) * 2014-12-19 2019-06-28 Intervet International B.V. Pestiwirus
BR112017028224A2 (pt) 2015-08-31 2018-09-11 Boehringer Ingelheim Vetmedica Gmbh composição, e, método para proteger um leitão contra uma doença associada a pestivírus.
CN106929606A (zh) * 2017-04-14 2017-07-07 华南农业大学 一种检测鉴定非典型猪瘟病毒（appv）的pcr引物及检测方法与检测试剂盒
CN110041411B (zh) * 2018-01-15 2023-10-03 浙江海隆生物科技有限公司 稳定的非典型猪瘟病毒亚单位蛋白及其疫苗和制备方法和应用
DE102018110208A1 (de) 2018-04-27 2019-10-31 Stiftung Tierärztliche Hochschule Hannover Gentechnisch veränderte Pestiviren und deren Verwendung als Markerimpfstoff
CN110652584A (zh) * 2018-06-29 2020-01-07 西北民族大学 猪瘟弱毒株与猪口蹄疫(o型)灭活抗原二联苗
CN111690778B (zh) * 2020-07-16 2022-06-03 四川农业大学 一种appv病毒的pcr引物、探针及其鉴别方法
CN111733289B (zh) * 2020-07-16 2022-04-05 四川农业大学 用于检测appv、csfv、pcv3和ptv1的引物组、探针及方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2681685T3 (es) * 2008-12-03 2018-09-14 Zoetis Services Llc Virus de la diarrea vírica bovina con una proteína Erns modificada
PL3233890T3 (pl) * 2014-12-19 2019-06-28 Intervet International B.V. Pestiwirus

Also Published As

Publication number Publication date
CN107002047B (zh) 2022-02-08
BR112017012484A2 (pt) 2018-02-27
RU2017125526A (ru) 2019-01-21
DK3233890T3 (en) 2019-04-15
ES2717544T3 (es) 2019-06-21
KR20170098871A (ko) 2017-08-30
JP2018500028A (ja) 2018-01-11
CN107002047A (zh) 2017-08-01
WO2016097245A1 (en) 2016-06-23
KR102472939B1 (ko) 2022-11-30
CA2968912A1 (en) 2016-06-23
BR112017012484B1 (pt) 2024-02-06
RU2017125526A3 (es) 2019-09-23
EP3233890A1 (en) 2017-10-25
PL3233890T3 (pl) 2019-06-28
US20170342387A1 (en) 2017-11-30
US10954491B2 (en) 2021-03-23
RU2710041C2 (ru) 2019-12-24
JP6772137B2 (ja) 2020-10-21
EP3233890B1 (en) 2019-02-06

Similar Documents

Publication Publication Date Title
MX2017008096A (es) Pestivirus.
MX2022006652A (es) Proteinas de capside modificadas para un suministro mejorado de vectores de parvovirus.
PH12017500861A1 (en) Anti-interleukin-33 antibodies and uses thereof
MX2023001834A (es) Anticuerpos antimiostatina, polipeptidos que contienen regiones fc variantes, y metodos de uso.
TWI799368B (zh) 抗ｔｌ１ａ抗原結合蛋白及相關核酸、表現載體、宿主細胞、醫藥組合物、方法及用途
PH12017502180A1 (en) Tau-binding antibodies
MX2016013584A (es) Parvovirus porcino.
MX2018002106A (es) Vacunas terapeuticas contra el hpv18.
MX2017009538A (es) Antigenos de citomegalovirus y su uso.
WO2014200910A3 (en) Bioinformatic processes for determination of peptide binding
EP3126837A4 (en) Peptides, reagents and methods for detecting food allergy
MY181175A (en) Therapeutic hpv16 vaccines
MX2022003706A (es) Anticuerpos anti-huntingtina (htt) derivados de humano y usos de los mismos.
MY193677A (en) Tau-binding antibodies
MX2017005661A (es) Celulas de mamifero que expresan antigenos de citomegalovirus.
MX2018012550A (es) Composiciones y metodos para la deteccion de proteinas de celulas huesped.
SG10201807572PA (en) Robust antibody purification
WO2015112558A3 (en) Peptides, devices, and methods for the detection of anaplasma antibodies
MX2019013124A (es) Proteinas de fusion de inhibidor de tripsina urinaria (uti).
BR112015004629A2 (pt) polipeptídeos de clostridium difficile como vacinas
TW201613981A (en) Compositions and methods for the diagnosis of rheumatoid arthritis
PH12017501100A1 (en) Recombinant swinepox virus and vaccines
WO2016007919A3 (en) Antibody fragments for detecting cancer and methods of use
WO2013138259A3 (en) Polypeptides for treating and/or limiting influenza infection
NZ731491A (en) Cd83 binding proteins and uses thereof